Skip to main content
. 2013 Feb;57(2):914–923. doi: 10.1128/AAC.01868-12

Table 2.

In vitro phenotype of culture-adapted parasites from Pailin and Ratanakiri collected in 2010 to 2011 and reference clones determined using the standard in vitro drug susceptibility assay, the ring-stage survival assay, and the recovery assay at D3, D6, and D10a

IPC ID Site SIA IC50 (nM)
RSA (%) RA (%)
AS DHA D3 D6 D10
5145 Pailin 0.7 0.77 14.2 1.70 3.78 47.83
4970 Pailin 0.8 0.34 15.5 NA NA NA
4992 Pailin 0.35 0.5 13.8 0.0 2.5 14.54
4248 Pailin 0.27 0.25 7.1 NA NA NA
5035 Pailin 2.92 4.79 7.1 NA NA NA
5100 Pailin 0.63 0.44 4.2 NA NA NA
5160 Pailin 0.21 0.3 19.6 NA NA NA
5168 Pailin 0.37 0.45 14.2 NA NA NA
5208 Pailin 0.63 0.6 3.9 NA NA NA
4971 Pailin 1.08 1.13 17.4 0.87 3.37 77.71
5188 Ratanakiri 0.31 0.2 3.3 NA NA NA
3592 Ratanakiri 1.1 1,00 1.6 0.0 0.88 10.66
5150 Ratanakiri 0.51 0.45 0.7 0.0 0,0 2.5
5055 Ratanakiri 0.31 0.32 0.16 NA NA NA
4974 Ratanakiri 0.5 0.23 1.3 0.0 0.0 3.48
5152 Ratanakiri 0.29 0.37 0.6 NA NA NA
5159 Ratanakiri 0.45 0.4 0.6 NA NA NA
4880 Ratanakiri 0.39 0.26 1.3 NA NA NA
5207 Ratanakiri 0.36 0.3 1.1 NA NA NA
4914 Ratanakiri 0.37 0.32 2.5 NA NA NA
3D7 Reference clone 0.58 0.47 0.8 NA NA NA
G15 Reference clone NA NA 3.5 NA NA NA
W2 Reference clone 0.71 0.63 5.4 NA NA NA
7G8 Reference clone NA NA 1.7 NA NA NA
HB3 Reference clone NA NA 0.6 NA NA NA
a

SIA, standard in vitro drug susceptibility assay; RSA, ring-stage survival assay; RA, recovery assay; AS, artesunate; DHA, dihydroartemisinin; IC50, 50% inhibitory concentration; RSA (%), percentage of viable parasites having developed into a second generation of rings or trophozoites at 66 h following exposure of ring stages; RA (%), percentage of recovery from the initial parasitemia.